Aura Biosciences, Inc. Capital Expenditures
Aura Biosciences, Inc. (AURA) reported Capital Expenditures of $123.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-11
- Aura Biosciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $21.00K, a 46.15% decline year-over-year.
- Aura Biosciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $102.00K, a 45.45% decline year-over-year.
- Aura Biosciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $176.00K, a 41.14% decline year-over-year.
- Aura Biosciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $45.00K, a 86.80% decline year-over-year.
- Aura Biosciences, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $447.00K, a 64.33% decline from fiscal 2024.
- Aura Biosciences, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $1.25M, a 76.73% increase from fiscal 2023.
- Aura Biosciences, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $709.00K, a 35.19% decline from fiscal 2022.
- Aura Biosciences, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $1.09M, a 48.52% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $123.00K 10-Q · filed 2026-08-11 | $299.00K derived: sum of 3 quarters · filed 2026-08-11 | $344.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $102.00K 10-Q · filed 2026-05-11 | $278.00K derived: sum of 2 quarters · filed 2026-05-11 | $323.00K derived: sum of 3 quarters · filed 2026-05-11 | $362.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $221.00K derived: sum of 2 quarters · filed 2026-03-30 | $260.00K derived: sum of 3 quarters · filed 2026-08-11 | $447.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $84.00K derived: sum of 2 quarters · filed 2026-08-11 | $271.00K 10-Q · filed 2025-11-13 | $570.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $226.00K 10-Q · filed 2026-08-11 | $525.00K derived: sum of 3 quarters · filed 2026-08-11 | $866.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $187.00K 10-Q · filed 2026-05-11 | $486.00K derived: sum of 2 quarters · filed 2026-05-11 | $827.00K derived: sum of 3 quarters · filed 2026-05-11 | $1.35M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $640.00K derived: sum of 2 quarters · filed 2026-03-30 | $1.17M derived: sum of 3 quarters · filed 2026-03-30 | $1.25M 10-K · filed 2026-03-30 |
| 2024-09-30 | $341.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $866.00K derived: sum of 2 quarters · filed 2025-11-13 | $954.00K 10-Q · filed 2025-11-13 | $1.27M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $525.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $613.00K 10-Q · filed 2025-08-13 | $930.00K derived: sum of 3 quarters · filed 2025-08-13 | $1.02M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $88.00K 10-Q · filed 2025-05-15 | $405.00K derived: sum of 2 quarters · filed 2025-05-15 | $495.00K derived: sum of 3 quarters · filed 2025-05-15 | $688.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $317.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $407.00K derived: sum of 2 quarters · filed 2025-03-24 | $600.00K derived: sum of 3 quarters · filed 2025-03-24 | $709.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $283.00K derived: sum of 2 quarters · filed 2024-11-12 | $392.00K 10-Q · filed 2024-11-12 | $750.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $302.00K 10-Q · filed 2024-08-08 | $660.00K derived: sum of 3 quarters · filed 2024-08-08 | $723.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $109.00K 10-Q · filed 2024-05-09 | $467.00K derived: sum of 2 quarters · filed 2024-05-09 | $530.00K derived: sum of 3 quarters · filed 2024-05-09 | $604.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $421.00K derived: sum of 2 quarters · filed 2024-03-27 | $495.00K derived: sum of 3 quarters · filed 2024-03-27 | $1.09M 10-K · filed 2024-03-27 |
| 2022-09-30 | $63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $137.00K derived: sum of 2 quarters · filed 2023-11-09 | $736.00K 10-Q · filed 2023-11-09 | $1.55M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $673.00K 10-Q · filed 2023-08-09 | $1.49M derived: sum of 3 quarters · filed 2023-08-09 | $2.06M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $599.00K 10-Q · filed 2023-05-11 | $1.42M derived: sum of 2 quarters · filed 2023-05-11 | $1.99M derived: sum of 3 quarters · filed 2023-05-11 | $2.65M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $819.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $1.39M derived: sum of 2 quarters · filed 2023-03-15 | $2.05M derived: sum of 3 quarters · filed 2023-03-15 | $2.13M 10-K · filed 2023-03-15 |
| 2021-09-30 | $573.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.24M derived: sum of 2 quarters · filed 2022-11-10 | $1.31M 10-Q · filed 2022-11-10 | $1.44M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $662.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $733.00K 10-Q · filed 2022-08-11 | $865.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $71.00K 10-Q · filed 2022-05-12 | $203.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $771.00K 10-K · filed 2022-03-23 | ||
| 2020-09-30 | $639.00K 10-Q · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |